STOCK TITAN

Sono-Tek Reports Increased Sales and Strong Backlog for Third Quarter Fiscal 2022 and Continues to Expect Record Annual Sales for FY2022

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary

Sono-Tek Corporation (SOTK) reported Q3 fiscal 2022 sales of $4.4 million, up 15% year-over-year. Gross profit rose 12% to $2.16 million, with a gross margin of 48.9%. Backlog reached a record $6.5 million, a 69% increase from the previous year. Operating income increased 10% to $491,000, with net income up 17.5% to $376,000. The company anticipates double-digit sales growth for Q4 and FY2022, expecting its highest annual sales in corporate history.

Positive
  • Q3 net sales increased 15% to $4.4M.
  • Record backlog of $6.5M, up 69% year-over-year.
  • Operating income up 10% to $491,000.
  • Net income increased 17.5% to $376,000.
Negative
  • Gross margin decreased to 48.9% from 50.5% due to product mix changes.

Q3 Sales of $4.4M, Up 15% Year-over-Year; Record Backlog of $6.5M, up 69% from FYE February 28, 2021

MILTON, N.Y., Jan. 12, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sono-Tek Corporation (NASDAQ: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today reported financial results for the third quarter and first nine-month periods of fiscal year 2022, ended November 30, 2021.

Third Quarter Fiscal 2022 Highlights (compared with the third quarter of fiscal 2021 unless otherwise noted). 

  • Net sales increased 15% to $4,419,000, driven by strong sales to Asia for medical device coating machines and clean energy coating systems.
  • Gross Profit increased 12% to $2,159,000 due to the increase in sales.
  • Gross Margin was 48.9% compared with 50.5% for the prior year period due to changes in product mix.
  • Operating income increased 10% to $491,000 due to the increase in gross profit, partially offset by increases in operating expenses.
  • Income before taxes increased 9% to $493,000.
  • Backlog on November 30, 2021 reached another record high of $6,505,000, an increase of 3% compared with backlog of $6,332,000 on August 31, 2021 (the end of the fiscal Q2) and increased 69% compared to backlog of $3,851,000 on February 28, 2021 (the end of fiscal year 2021).

Nine Month Fiscal 2022 Highlights (compared with the first nine months of fiscal 2021 unless otherwise noted)

  • Net Sales increased 13% to $12,134,000, primarily driven by sales of several recently developed new products for the medical market as well as continued expansion of Sono-Tek systems used in the clean energy sector. 
  • Gross Profit increased 18% to $6,057,000 due to higher sales and a favorable product mix.
  •  Gross Margin expanded 230 basis points to 49.9% primarily due to a favorable product mix and lower than expected warranty and installation costs.
  • Operating Income increased 54% to $1,282,000 due to the increase in gross profit, partially offset by increases in operating expenses.
  • Income before taxes increased 50% to $1,295,000, excluding the benefit from PPP loan forgiveness of $1.0 million.
  • As of November 30, 2021, the Company had no outstanding debt.
  • Cash and marketable securities were $10,184,000 on November 30, 2021, an increase of $1,537,000 from February 28, 2021, nearly half of which was due to an increase in customer deposits of $729,000, bringing total deposits to $1,896,000 at November 30, 2021.  The increase in customer deposits is primarily due to our record backlog and the growing percentage of orders for costly, complex systems in the backlog.

Guidance

  • For the fourth quarter of FY2022, Sono-Tek expects double digit sales growth over the comparable period of the prior fiscal year.
  • Sono-Tek anticipates double digit sales growth for FY2022, and continues to expect the highest annual sales in corporate history for the fiscal year ending February 28, 2022.

Dr. Christopher L. Coccio, Chairman and CEO, commented, “Sono-Tek had an excellent third quarter with sales and net income growth of 15% and 10%, respectively. This was the third consecutive quarter of sales increases and strong results in backlog, margins, and net income, which were achieved against the backdrop of an uncertain global environment with limited travel for sales and service personnel and the continuing impact of supply chain issues on our production schedules. We correctly anticipated this issue and deployed some of the Company’s significant cash reserves to purchase additional key inventory items earlier in the fiscal year. We also utilized creative hiring approaches and higher compensation to offset the shortage of labor that developed and leveraged Sono-Tek’s strong IT infrastructure to engage with customers on a virtual basis when in-person visits were not feasible.”

“We ended the third quarter with $10.2 million in cash, no debt and reached another record for backlog of $6.5 million, reflecting the high activity levels in our development labs. Sales for the fourth quarter of FY2022 are expected to increase by double digits over the comparable period last year. For the full fiscal year, ending February 28, 2022, we continue to expect to report the highest annual sales in corporate history.”

“Sono-Tek’s multi-year financial gains stem from the strategic shift in the Company’s business model that was initiated several years ago, expanding its product line to provide higher value complete machine solutions and larger subsystems to original equipment manufacturers (“OEMs”). These product advancements are supported by a high level of application engineering expertise from our specialized staff, in combination with the Company’s globally located process development labs. Looking ahead, we believe that the gains from this shift will continue to be realized as we continue to invest significant resources to further enhance our market diversity with new and expanded applications for Sono-Tek’s unique ultrasonic coating systems,” concluded Dr. Coccio.

Year-to-Date Fiscal 2022 Results (Narrative compares with prior-year period unless otherwise noted)

 ($ in thousands)

  Nine Months Ended November 30,     Change
  2021   2020   $   %
Net Sales  $   12,134    $   10,736        1,398   13%
Gross Profit  $     6,057    $     5,112   945   18%
     Gross Margin 49.9%   47.6%        
               
Operating Income  $     1,282    $        832   450   54%
     Operating Margin 10.6%   7.8%        
               
Net Income  $     1,987    $       666           1,321   198%
     Net Margin 16.4%   6.2%        
               
               

Third Quarter Fiscal 2022 Results (Narrative compares with prior-year period unless otherwise noted)

 ($ in thousands)

  Three Months Ended November 30,     Change
  2021   2020   $   %
Net Sales  $     4,419    $     3,827       592   15%
Gross Profit  $     2,159    $     1,931           228   12%
     Gross Margin 48.9%   50.5%        
               
Operating Income  $       491    $       447           44   10%
     Operating Margin 11%   12%        
               
Net Income  $        376    $        320            56   18%
     Net Margin 8.5%   8.4%        


Third Quarter FY2022 Financial Overview

Fiscal third quarter net sales were $4,419,000, up 15% from the third quarter of last year.

Sales of multi-axis coating systems were strong, increasing $1.5 million or 118% year-over-year, driven by continued demand for membrane coating systems used in fuel cells and carbon capture applications in the alternative clean energy sector as well as sales of new medical device coating systems, including a newly developed full system solution for drug delivery coating onto a consumable medical device that shipped to China.  

Integrated coatings systems sales decreased by $1.0 million or 94% in the third quarter.  This was due to the shipments of two large orders in last year’s third quarter -- for a textile coating machine and a solar cell coating machine -- neither of which repeated in the current period.

The micro-electronics market also dipped in the third quarter. However, this market sector is expected to rebound in the current fourth quarter due to the planned delivery of a large six-axis robot for the semiconductor industry that is scheduled to ship by the end of Sono-Tek’s fiscal year in February.  

In the third quarter of fiscal 2022, approximately 78% of sales originated outside of the United States and Canada compared with 70% in the prior year period. 

Strong sales in Q3 fiscal 2022 were primarily driven from sales to APAC, reflecting the continuing transition of several countries emerging from COVID-19 lockdowns to bring their manufacturing operations back online. APAC shipments during the third quarter included two significant fuel cell membrane coating systems that were sold to different customers in South Korea that together totaled over $550,000, as well as continued strong demand for Sono-Tek’s balloon catheter coating systems that were sold into several different regions of APAC.  

At quarter end, backlog was a record high of $6,505,000, an increase of 3% compared with backlog of $6,332,000 on August 31, 2021 (the end of the fiscal Q2) and increased 69% compared to backlog of $3,851,000 on February 28, 2021 (the end of fiscal year 2021).

For the third quarter of fiscal 2022, Gross Profit increased 12% to $2,159,000 due to the increase in sales. Gross Margin was 48.9% compared with 50.5% for the prior year period due to increased sales of products with lower sales margins, and an increase in overseas sales which are typically sold through our international distribution partners at distributor discounted prices.

Operating income increased 9.8% to $491,000 compared with $447,000 for the prior year period primarily due to growth in revenue and gross profit. Operating margin for the third quarter of fiscal 2022 was 11.1% compared with 11.7% in the prior year period.

Net income for the third quarter was $376,000, an increase of 17.5%, compared with $320,000 for the prior year period. The increase is a result of the increase in operating income combined with a decrease in income taxes. On a per share basis, earnings were $0.02 compared with $0.02 for the prior year period. Diluted weighted average shares outstanding totaled 15,654,936 compared to 15,583,089 for the prior year period.

Balance Sheet and Cash Flow Overview

Cash and cash equivalents and short-term investments at November 30, 2021 were $10.2 million, an increase of $1.6 million from February 28, 2021, the end of fiscal year 2021.  The increase was primarily the result of growth in the current period’s net income and noncash charges partially offset by purchases of equipment.

Capital expenditures in the third quarter totaled $285,000 and were directed to ongoing upgrades of the Company’s manufacturing and development lab facilities.  Sono-Tek anticipates that capital expenditures will total approximately $300,000 - $350,000 for fiscal year 2022.

At November 30, 2021, the Company had no debt on its balance sheet.

About Sono-Tek

Sono-Tek Corporation is the leading developer and manufacturer of ultrasonic coating systems for applying precise, thin film coatings to protect, strengthen or smooth surfaces on parts and components for the microelectronics/electronics, alternative energy, medical and industrial markets, including specialized glass applications in construction and automotive.

The Company’s solutions are environmentally-friendly, efficient and highly reliable, and enable dramatic reductions in overspray, savings in raw material, water and energy usage and provide improved process repeatability, transfer efficiency, high uniformity and reduced emissions.

Sono-Tek’s growth strategy is focused on leveraging its innovative technologies, proprietary know-how, unique talent and experience, and global reach to further develop thin film coating technologies that enable better outcomes for its customers’ products and processes.  For further information, visit www.sono-tek.com.

Safe Harbor Statement

This news release contains forward looking statements regarding future events and the future performance of Sono-Tek Corporation that involve risks and uncertainties that could cause actual results to differ materially. These “forward-looking statements’ are based on currently available competitive, financial and economic data and our operating plans.  They are inherently uncertain, and investors must recognize that events could turn out to be significantly different from our expectations and could cause actual results to differ materially. These factors include, among other considerations, general economic and business conditions; political, regulatory, tax, competitive and technological developments affecting our operations or the demand for our products; the duration and scope of the COVID-19 pandemic; the extent and duration of the pandemic’s adverse effect on economic and social activity, consumer confidence, discretionary spending and preferences, labor and healthcare costs, and unemployment rates, any of which may reduce demand for some of our products and impair the ability of those with whom we do business to satisfy their obligations to us; our ability to sell and provide our services and products, including as a result of continued pandemic related travel restrictions, mandatory business closures, and stay-at home or similar orders; any temporary reduction in our workforce, closures of our offices and facilities and our ability to adequately staff and maintain our operations resulting from the pandemic; the ability of our customers and suppliers to continue their operations as result of the pandemic, which could result in terminations of contracts, losses of revenue; the continued recovery of the Microelectronics, Medical and Alternative Energy markets following COVID-19 related slowdowns; and further adverse effects to our supply chain; maintenance of increased order backlog, including effects of any COVID-19 related cancellations; the imposition of tariffs; the continued strong sales of the multi-axis coatings systems; timely development and market acceptance of new products and continued customer validation of our coating technologies; adequacy of financing; capacity additions, the ability to enforce patents; maintenance of operating leverage; maintenance of increased order backlog; consummation of order proposals; completion of large orders on schedule and on budget; continued sales growth in the medical and alternative energy markets; successful transition from primarily selling ultrasonic nozzles and components to a more complex business providing complete machine solutions and higher value subsystems; and realization of quarterly and annual revenues within the forecasted range of sales guidance. We undertake no obligation to update any forward-looking statement.

For more information, contact:

Stephen J. Bagley
Chief Financial Officer
Sono-Tek Corporation
info@sono-tek.com

Investor Relations:
Stephanie Prince
PCG Advisory
(646) 863-6341
sprince@pcgadvisory.com

SONO-TEK CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS

    November 30,          
    2021       February 28,    
    (Unaudited)       2021    
ASSETS                
                 
Current Assets:                    
Cash and cash equivalents   $ 6,833,804       $ 4,084,078    
Marketable securities     3,349,962         4,563,470    
Accounts receivable (less allowance of $56,123)     1,563,460         1,757,802    
Inventories, net     2,799,763         2,611,106    
Prepaid expenses and other current assets     139,856         151,316    
  Total current assets     14,686,845         13,167,772    
                     
Land     250,000         250,000    
Buildings, net     1,501,369         1,575,135    
Equipment, furnishings and building improvements, net     1,114,606         1,075,190    
Intangible assets, net     80,875         95,456    
Deferred tax asset     236,120         259,838    
                     
TOTAL ASSETS   $ 17,869,815       $ 16,423,391    
                     
LIABILITIES AND STOCKHOLDERS’ EQUITY                    
                     
Current Liabilities:                    
Accounts payable   $ 876,283       $ 1,294,483    
Accrued expenses     1,733,451         1,750,916    
Customer deposits     1,895,671         1,166,541    
Income taxes payable     142,517         53,567    
   Total current liabilities     4,647,922         4,265,507    
                     
Deferred tax liability     183,011         205,562    
Long term debt, less current maturities     -         1,001,640    
   Total liabilities     4,830,933         5,472,709    
                     
Stockholders’ Equity                    
Common stock, $.01 par value; 25,000,000 shares authorized, 15,699,719 and 15,452,656 shares issued and outstanding, respectively     156,997         154,527    
Additional paid-in capital     9,163,979         9,064,994    
Accumulated earnings     3,717,906         1,731,161   
   Total stockholders’ equity     13,038,882         10,950,682    
                     
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY   $ 17,869,815       $ 16,423,391    

See notes to unaudited condensed consolidated financial statements.

SONO-TEK CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)

    Nine Months Ended
November 30,
    Three Months Ended
November 30,
 
    2021     2020     2021     2020  
                         
Net Sales   $ 12,134,336     $ 10,736,327     $ 4,419,401     $ 3,827,142  
Cost of Goods Sold     6,077,645       5,624,002       2,260,874       1,896,516  
        Gross Profit     6,056,691       5,112,325       2,158,527       1,930,626  
                                 
Operating Expenses                                
Research and product development costs     1,243,513       1,241,739       417,300       406,799  
Marketing and selling expenses     2,349,607       2,154,956       845,362       765,969  
General and administrative costs     1,181,502       883,384       405,280       311,130  
            Total Operating Expenses     4,774,622       4,280,079       1,667,942       1,483,898  
                                 
Operating Income     1,282,069       832,246       490,585       446,728  
                                 
Interest Expense     -       (23,949 )     -       (6,245 )
Interest and Dividend Income     13,367       26,953       2,367       1,470  
Other Income     -       30,343       -       10,824  
Paycheck Protection Program Loan Forgiveness     1,005,372       -       -       -  
                                 
Income Before Income Taxes     2,300,808       865,593       492,952       452,777  
                                 
Income Tax Expense     314,063       199,424       116,783       132,299  
                                 
Net Income   $ 1,986,745     $ 666,169     $ 376,169     $ 320,478  
                                 
Basic Earnings Per Share   $ 0.13     $ 0.04     $ 0.02     $ 0.02  
                                 
Diluted Earnings Per Share   $ 0.13     $ 0.04     $ 0.02     $ 0.02  
                                 
Weighted Average Shares - Basic     15,541,247       15,420,787       15,622,721       15,440,673  
                                 
Weighted Average Shares - Diluted     15,572,424       15,547,604       15,654,936       15,583,089  

See notes to unaudited condensed consolidated financial statements.

SONO-TEK CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)

    Unaudited  
    Nine Months Ended
November 30,
 
    2021     2020  
             
CASH FLOWS FROM OPERATING ACTIVITIES:                
Net Income   $ 1,986,745     $ 666,169  
Adjustments to reconcile net income to net cash provided by operating activities:                
Depreciation and amortization     333,729       350,043  
Stock based compensation expense     92,680       26,973  
Inventory reserve     (3,919     54,000  
Paycheck Protection Program Loan Forgiveness                  (1,005,372)       -  
Deferred tax expense     23,718       (89,304)  
Decrease (Increase) in:                
   Accounts receivable     194,342       (744,282)  
   Inventories     (184,738 )     (119,211)  
   Prepaid expenses and other current assets     11,460       27,071  
(Decrease) Increase in:                
   Accounts payable and accrued expenses     (431,934     193,317  
   Customer deposits     729,130       133,423  
   Income taxes payable     66,400       214,725  
Net Cash Provided by Operating Activities     1,812,241       712,924  
                 
CASH FLOWS FROM INVESTING ACTIVITIES:                
Purchase of equipment, furnishings and leasehold improvements     (284,798 )     (327,180 )
Capital expenditure grant proceeds     -       100,000  
Sale  of marketable securities     1,213,508       993,724  
Net Cash Provided by Investing Activities     928,710       766,544  
                 
CASH FLOWS FROM FINANCING ACTIVITIES:                
     Proceeds from exercise of stock options     8,775       -  
Proceeds from note payable     -       1,001,640  
Repayment of long term debt     -       (126,650 )
Net Cash Provided by Financing Activities     8,775       874,990  
                 
NET INCREASE IN CASH AND CASH EQUIVALENTS     2,749,726       2,354,458  
                 
CASH AND CASH EQUIVALENTS                
Beginning of period     4,084,078       3,659,551  
End of period   $ 6,833,804     $ 6,014,009  
                 
SUPPLEMENTAL CASH FLOW DISCLOSURE:                
Interest paid   $ -     $ 20,573  
Income Taxes Paid   $ 224,002     $ 74,004  

See notes to unaudited condensed consolidated financial statements.

SONO-TEK CORPORATION
PRODUCT, MARKET, AND GEOGRAPHIC SALES
(Unaudited)

Product Sales

    Three Months Ended
November 30,
    Change     Nine Months Ended
November 31,
    Change  
    2021     2020     $     %     2021     2020     $     %  
Fluxing Systems   $ 104,000     $ 242,000       (138,000 )     (57% )   $ 579,000     $ 680,000       (101,000)       (15%
Integrated Coating Systems     60,000       1,071,000       (1,011,000     (94%     780,000       2,920,000       (2,140,000)       (73%
Multi-Axis Coating Systems     2,721,000       1,249,000       1,472,000       118%       6,692,000       4,147,000       2,545,000       61%  
OEM Systems     637,000       523,000       114,000       22%       1,808,000       1,177,000       631,000       54%  
Other     897,000       742,000       155,000       21%       2,275,000       1,812,000       463,000       26%  
TOTAL   $ 4,419,000     $ 3,827,000       592,000       15%     $ 12,134,000     $ 10,736,000       1,398,000       13%  

Market Sales

    Three Months Ended
November 30,
    Change     Nine Months Ended
November 30,
    Change  
    2021     2020     $     %     2021     2020     $     %  
Electronics/Microelectronics   $ 898,000     $ 1,455,000       (557,000)       (38%   $ 4,605,000     $ 4,504,000       101,000       2%  
Medical     1,604,000       831,000       773,000       93%       3,418,000       2,484,000       934,000       38%  
Alternative Energy     1,459,000       783,000       676,000       86%       2,848,000       2,004,000       844,000       42%  
Emerging R&D and Other     256,000       207,000       49,000       24%       691,000       723,000       (32,000     (4%)  
Industrial     202,000       551,000       (349,000)        (63%)       572,000       1,021,000       (449,000)       (44% )
TOTAL   $ 4,419,000     $ 3,827,000       592,000       15%     $ 12,134,000     $ 10,736,000       1,398,000       13%  

Geographic Sales

    Three Months Ended
November 30,
    Change     Nine Months Ended
November 30,
    Change  
    2021     2020     $     %     2021     2020     $     %  
U.S. & Canada   $ 988,000     $ 1,165,000         (177,000)       (15% )   $ 3,769,000     $ 4,076,000       (307,000)       (8%
Asia Pacific (APAC)     1,901,000       1,039,000       862,000       83%       4,754,000       3,416,000       1,338,000       39%  
Europe, Middle East, Asia (EMEA)     1,287,000       1,216,000       71,000       6%       2,723,000       2,414,000       309,000       13%  
Latin America     243,000       407,000       (164,000     (40%     888,000       830,000       58,000       7%  
TOTAL   $ 4,419,000     $ 3,827,000       592,000       15%     $ 12,134,000     $ 10,736,000       1,398,000       13%  

FAQ

What are Sono-Tek's sales results for Q3 fiscal 2022?

Sono-Tek reported Q3 fiscal 2022 sales of $4.4 million, which is a 15% increase year-over-year.

How much did Sono-Tek's backlog increase in Q3 fiscal 2022?

The backlog reached a record $6.5 million, reflecting a 69% increase from the previous year.

What is Sono-Tek's guidance for Q4 and FY2022?

Sono-Tek expects double-digit sales growth for Q4 and anticipates reporting the highest annual sales in corporate history for FY2022.

What was Sono-Tek's net income for Q3 fiscal 2022?

Net income for Q3 fiscal 2022 was $376,000, an increase of 17.5% compared to the prior year.

Sono-Tek Corporation

NASDAQ:SOTK

SOTK Rankings

SOTK Latest News

SOTK Stock Data

65.60M
12.22M
16.21%
47.91%
0.05%
Scientific & Technical Instruments
Special Industry Machinery, Nec
Link
United States of America
MILTON